title: Impairment of adolescent hippocampal plasticity in a mouse model for Alzheimer's disease precedes disease phenotype.
abstract: The amyloid precursor protein (APP) was assumed to be an important neuron-morphoregulatory protein and plays a central role in Alzheimer's disease (AD) pathology. In the study presented here, we analyzed the APP-transgenic mouse model APP23 using 2-dimensional gel electrophoresis technology in combination with DIGE and mass spectrometry. We investigated cortex and hippocampus of transgenic and wildtype mice at 1, 2, 7 and 15 months of age. Furthermore, cortices of 16 days old embryos were analyzed. When comparing the protein patterns of APP23 with wildtype mice, we detected a relatively large number of altered protein spots at all age stages and brain regions examined which largely preceded the occurrence of amyloid plaques. Interestingly, in hippocampus of adolescent, two-month old mice, a considerable peak in the number of protein changes was observed. Moreover, when protein patterns were compared longitudinally between age stages, we found that a large number of proteins were altered in wildtype mice. Those alterations were largely absent in hippocampus of APP23 mice at two months of age although not in other stages compared. Apparently, the large difference in the hippocampal protein patterns between two-month old APP23 and wildtype mice was caused by the absence of distinct developmental changes in the hippocampal proteome of APP23 mice. In summary, the absence of developmental proteome alterations as well as a down-regulation of proteins related to plasticity suggest the disturption of a normally occurring peak of hippocampal plasticity during adolescence in APP23 mice. Our findings are in line with the observation that AD is preceded by a clinically silent period of several years to decades. We also demonstrate that it is of utmost importance to analyze different brain regions and different age stages to obtain information about disease-causing mechanisms.
authors.affiliation: Institute for Human Genetics, Charité-University Medicine, Berlin, Germany.
authors.forename: Daniela
authors.initials: D
authors.lastname: Hartl
authors.forename: Michael
authors.initials: M
authors.lastname: Rohe
authors.forename: Lei
authors.initials: L
authors.lastname: Mao
authors.forename: Matthias
authors.initials: M
authors.lastname: Staufenbiel
authors.forename: Claus
authors.initials: C
authors.lastname: Zabel
authors.forename: Joachim
authors.initials: J
authors.lastname: Klose
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics* / Q000378:metabolism*; D000818:Animals; D002540:Cerebral Cortex / Q000196:embryology / Q000378:metabolism; D004195:Disease Models, Animal; D018450:Disease Progression; D015180:Electrophoresis, Gel, Two-Dimensional; D019922:GAP-43 Protein / Q000378:metabolism; D005786:Gene Expression Regulation; D006624:Hippocampus / Q000196:embryology / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009473:Neuronal Plasticity; D010641:Phenotype; D040901:Proteomics / Q000379:methods; D013997:Time Factors
chemical_list: D019922:GAP-43 Protein